Scientists in China have developed a new intranasal flu vaccine using nano-technology that can target broad-spectrum flu viruses and induce robust immune responses.
The intranasal nano-vaccine was developed by a research group from Wuhan Institute of Virology of China announced that they have developed a new type of flu vaccine using nano-technology.
The intranasal nano-vaccine can target broad-spectrum flu viruses and induces robust immune responses, Cui Zongqiang, leader of the research group said.
"In our study, an intranasal nano-vaccine worked well against infections of H1N1 and H9N2 virus in mice," Cui said.
"The results suggest that the 3M2e-rHF nanoparticle is a promising, needle-free, intranasal administered, cross-protective influenza vaccine," he was quoted as saying by state-run Xinhua news agency.
Across China, measures have been taken to contain the winter flu outbreak.
Experts said flu infections this winter are 71 per cent above the average for the same period in the previous three years, with child cases rising sharply.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.